[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585097":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":28,"centralContacts":32,"locations":38,"responsibleParty":202,"collaborators":28,"id":204,"slug":205,"hasResults":206,"nctId":207,"briefTitle":208,"officialTitle":209,"acronym":28,"eligibilityCriteria":210,"healthyVolunteers":206,"sex":211,"minAge":212,"maxAge":213,"enrollmentInfo":214,"targetDuration":28,"studyType":217,"phases":218,"briefSummary":221,"conditions":222,"keywords":224,"overallStatus":100,"whyStopped":28,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":238},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"AZD0120","EXPERIMENTAL","Single dose of AZD0120",[13,14,15],"Biological: AZD0120","Drug: Cyclophosphamide","Drug: Fludarabine",[17,23,29],{"type":18,"name":9,"description":19,"armGroupLabels":20,"otherNames":21},"BIOLOGICAL","Single infusion of AZD0120 on visit DAY 1 after completing required lymphodepleting chemotherapy..",[9],[22],"GC012F",{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","Cyclophosphamide","Lymphodepletion - specified dose prior to receiving AZD0120",[9],null,{"type":24,"name":30,"description":26,"armGroupLabels":31,"otherNames":28},"Fludarabine",[9],[33],{"name":34,"role":35,"phone":36,"phoneExt":28,"email":37},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[39,53,61,71,80,89,99,109,118,126,134,143,151,160,169,174,184,192],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":28},"Research Site","NOT_YET_RECRUITING","San Francisco","California","94143","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-122.41942,37.77493,{"lat":51,"lon":50},{"facility":40,"status":41,"city":54,"state":43,"zip":55,"country":45,"countryCode":46,"cosmosGeoPoint":56,"geoPoint":60,"contacts":28},"Stanford","94304-2201",{"type":48,"coordinates":57},[58,59],-122.16608,37.42411,{"lat":59,"lon":58},{"facility":40,"status":62,"city":63,"state":64,"zip":65,"country":45,"countryCode":46,"cosmosGeoPoint":66,"geoPoint":70,"contacts":28},"SUSPENDED","Tampa","Florida","33612",{"type":48,"coordinates":67},[68,69],-82.45843,27.94752,{"lat":69,"lon":68},{"facility":40,"status":41,"city":72,"state":73,"zip":74,"country":45,"countryCode":46,"cosmosGeoPoint":75,"geoPoint":79,"contacts":28},"Atlanta","Georgia","30322",{"type":48,"coordinates":76},[77,78],-84.38798,33.749,{"lat":78,"lon":77},{"facility":40,"status":41,"city":81,"state":82,"zip":83,"country":45,"countryCode":46,"cosmosGeoPoint":84,"geoPoint":88,"contacts":28},"Chicago","Illinois","60611",{"type":48,"coordinates":85},[86,87],-87.65005,41.85003,{"lat":87,"lon":86},{"facility":40,"status":90,"city":91,"state":92,"zip":93,"country":45,"countryCode":46,"cosmosGeoPoint":94,"geoPoint":98,"contacts":28},"WITHDRAWN","Bethesda","Maryland","20892",{"type":48,"coordinates":95},[96,97],-77.10026,38.98067,{"lat":97,"lon":96},{"facility":40,"status":100,"city":101,"state":102,"zip":103,"country":45,"countryCode":46,"cosmosGeoPoint":104,"geoPoint":108,"contacts":28},"RECRUITING","Boston","Massachusetts","02115",{"type":48,"coordinates":105},[106,107],-71.05977,42.35843,{"lat":107,"lon":106},{"facility":40,"status":41,"city":110,"state":111,"zip":112,"country":45,"countryCode":46,"cosmosGeoPoint":113,"geoPoint":117,"contacts":28},"St Louis","Missouri","63110",{"type":48,"coordinates":114},[115,116],-90.19789,38.62727,{"lat":116,"lon":115},{"facility":40,"status":100,"city":119,"state":119,"zip":120,"country":45,"countryCode":46,"cosmosGeoPoint":121,"geoPoint":125,"contacts":28},"New York","10032",{"type":48,"coordinates":122},[123,124],-74.00597,40.71427,{"lat":124,"lon":123},{"facility":40,"status":100,"city":127,"state":119,"zip":128,"country":45,"countryCode":46,"cosmosGeoPoint":129,"geoPoint":133,"contacts":28},"Syracuse","13202-2240",{"type":48,"coordinates":130},[131,132],-76.14742,43.04812,{"lat":132,"lon":131},{"facility":40,"status":41,"city":135,"state":136,"zip":137,"country":45,"countryCode":46,"cosmosGeoPoint":138,"geoPoint":142,"contacts":28},"Chapel Hill","North Carolina","27599-7280",{"type":48,"coordinates":139},[140,141],-79.05584,35.9132,{"lat":141,"lon":140},{"facility":40,"status":100,"city":144,"state":136,"zip":145,"country":45,"countryCode":46,"cosmosGeoPoint":146,"geoPoint":150,"contacts":28},"Charlotte","28204",{"type":48,"coordinates":147},[148,149],-80.84313,35.22709,{"lat":149,"lon":148},{"facility":40,"status":41,"city":152,"state":153,"zip":154,"country":45,"countryCode":46,"cosmosGeoPoint":155,"geoPoint":159,"contacts":28},"Richmond","Virginia","23298",{"type":48,"coordinates":156},[157,158],-77.46026,37.55376,{"lat":158,"lon":157},{"facility":40,"status":100,"city":161,"state":162,"zip":163,"country":45,"countryCode":46,"cosmosGeoPoint":164,"geoPoint":168,"contacts":28},"Seattle","Washington","98104",{"type":48,"coordinates":165},[166,167],-122.33207,47.60621,{"lat":167,"lon":166},{"facility":40,"status":100,"city":161,"state":162,"zip":170,"country":45,"countryCode":46,"cosmosGeoPoint":171,"geoPoint":173,"contacts":28},"98195",{"type":48,"coordinates":172},[166,167],{"lat":167,"lon":166},{"facility":40,"status":41,"city":175,"state":28,"zip":176,"country":177,"countryCode":178,"cosmosGeoPoint":179,"geoPoint":183,"contacts":28},"Darlinghurst","2010","Australia","AU",{"type":48,"coordinates":180},[181,182],151.21925,-33.87939,{"lat":182,"lon":181},{"facility":40,"status":41,"city":185,"state":28,"zip":186,"country":177,"countryCode":178,"cosmosGeoPoint":187,"geoPoint":191,"contacts":28},"Melbourne","3000",{"type":48,"coordinates":188},[189,190],144.96332,-37.814,{"lat":190,"lon":189},{"facility":40,"status":41,"city":193,"state":28,"zip":194,"country":195,"countryCode":196,"cosmosGeoPoint":197,"geoPoint":201,"contacts":28},"Toronto","M5T 2S8","Canada","CA",{"type":48,"coordinates":198},[199,200],-79.39864,43.70643,{"lat":200,"lon":199},{"type":203,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100585097","phase-1-a-study-to-investigate-the-safety-tolerability-and-efficacy-of-azd0120-in-adults-with-refractory-sle-100585097",false,"NCT06897930","A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE","A Phase 1b\u002F2 Study of AZD0120, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Refractory Systemic Lupus Erythematosus (SLE)","INCLUSION:\n\n1. Males or females aged 18 through 70 years inclusive at the time of consent.\n2. Written informed consent in accordance with federal, local, and institutional guidelines.\n3. Must be able and willing to adhere to the study visit schedule and other protocol requirements\n4. Adequate hepatic, renal, pulmonary, and cardiac function\n5. Have a clinical diagnosis of SLE according to the EULAR\u002F American College of Rheumatology (ACR) 2019 criteria with a positive ANA ≥1:80 and a score ≥10.\n6. Have used at least two standard immunosuppressants (including one biological agent).\n7. SLEDAI-2K score ≥6 at screening.\n8. Must include a significant SLE related organ involvement: arthritis, myositis, rash, alopecia, mucosal ulcers, pleurisy, pericarditis, vasculitis, or renal.\n9. For lupus nephritis: Diagnosis of proliferative lupus nephritis based on a renal biopsy obtained within 6 months prior to signing the informed consent form or during the screening period Class III, IV or V LN according to the WHO 2003 ISN\u002FRPS classification.\n\nEXCLUSION:\n\n1. Have received prior treatment with CAR T therapy directed at any target.\n2. Have received any therapy that is targeted to CD19 and\u002For BCMA\n3. Received allogenic stem cell transplant or autologous stem cell transplant.\n4. An active malignancy that is progressing or requires active treatment.\n5. Primary immunodeficiency\n6. Active viral or bacterial infection","ALL","18 Years","70 Years",{"count":215,"type":216},150,"ESTIMATED","INTERVENTIONAL",[219,220],"PHASE1","PHASE2","This is a Phase 1b\u002F2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19\u002FBCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants with refractory Systemic Lupus Erythematosus.",[223],"Lupus Erythematosus, Systemic",[9,225,226,227,228],"SLE","Systemic Lupus Erythematosus","Lupus","Lupus Nephritis","2026-06-09",{"date":231,"type":232},"2026-06-10","ACTUAL",{"date":234,"type":232},"2025-04-21",{"date":236,"type":216},"2029-05-01",{"name":5,"class":6},18]